It is with great pleasure that we invite you to attend the 8th Asia Pacific Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) to be held in Shanghai, China, May 9-10, 2020.
The great success of the previous seven CODHy AP Congresses held in Shanghai, as well as the enthusiastic feedback received from the most recent Congress, confirmed the need for proceeding with the 8th edition of this dynamic Congress.
CODHy AP will be devoted to evidence-based debates and discussions amongst session moderators, speakers and the audience, all of whom will examine and analyze the most relevant and controversial issues raised during the course of 2019 and 2020 within the field of Diabetes, Obesity and Hypertension. Topics will include the treatment of type 2 diabetes such as personalized therapy, treatment targets, prediabetes, early stage diabetes, the role of insulin and other agents, advances in endocrinology as well as novel medical issues.
Allowing ample time for speaker-audience discussion, the Congress aims at reaching up-to-date recommendations to ongoing debates even when data remain limited, through evidence-based medicine, including expert opinion. Participants will have the opportunity to take part in this vibrant meeting which will facilitate discussions on the shared experiences and opinions of leading local and international experts.
The 8th CODHy AP Congress will emphasize issues related to the region in terms of diagnostics, distinctive responses to treatments and typical complications. Many of the Faculty members will be local in order to discuss these typical regional problems.
We invite you to join us at the 8th CODHy AP Congress and we look forward to seeing you in Shanghai in May.
Prof. Guang Ning and Prof. Itamar Raz
CODHy AP Co-Chairs